, Hong Kong

Hong Kong-listed L'Occitane to buy skincare brand Elemis for US$900m

The luxury cosmetics firm is building its UK and US foothold.

Bloomberg reports that Hong Kong-listed luxury cosmetics firm L’Occitane International SA has agreed to acquire beauty and skincare brand Elemis for US$900m in an attempt to expand its presence in the UK and US. 

L’Occitane, which creates cosmetic products based on natural ingredients, is buying Elemis USA from international business firm Steiner Leisure. It is also buying Elemis Ltd. from private firm Nemo U.K.

The purchase will be funded by L’Occitane’s cash and bank borrowings. The deal is expected to close in Q1 2019, according to the filing.

“This is L’Occitane’s largest acquisition since listing and a major step forward in building a group of premium beauty brands,” Reinold Geiger, chief executive officer of the firm, said in a statement.

L’ Occitane listed in Hong Kong in 2010 in a bid to grow its foothold in Asia.

Here’s more from Bloomberg

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Hong Kong and Shanghai to enhance financial ties
The two cities will leverage on their competitive advantage to boost their financial cooperation.
HK Express load factors exceed 97% in April amidst Easter holidays
Current bookings to North Asian destinations exceed 90% occupancy as Golden Week approaches.
Aviation
PolyU partners with ZEISS for myopia control tech advancement
The partnership focuses on developing myopia control and other ophthalmic technologies.
Healthcare